With 3 Granted Patents and 41 Pending, Small Pharma Is On Track To Be One Of Europe’s Biggest Psychedelic Companies
These are exciting times for us all at Small Pharma, with an expanding patent portfolio,…
Small Pharma’s first phase clinical trials prove promising for DMT-assisted therapy
Our CMSO Carol Routledge spoke to Mental Health Today about Small Pharma and its history…
Companies Compete to Create DMT Therapies
Lucid News has published an article covering the landscape of companies working to create DMT…
Psychedelic solution for depression: British drug firm starts clinical trials of new treatment that sends patients on a hallucinogenic trip
Small Pharma is carrying out clinical trials of a drug based on chemical DMT It…
Powerful hallucinogenic drug used in shamanic rituals is being trialled in the UK as a cure for depression
The hallucinogenic drug DMT is being trialled on British depression patients It is hoped it…
UK psychedelics firm Small Pharma raises cash to fund reverse takeover on Toronto Stock Exchange
The company, which is researching the potential of N, N-Dimethyltryptamine (DMT) as a treatment for…
Psychedelic therapy could ‘reset’ depressed brain
A powerful hallucinogenic drug known for its part in shamanic rituals is being trialled as…
‘First Ever’ DMT Trials to Take Place in the UK
Small Pharma, a pharmaceutical company that focuses on depression and mental health, has secured approval to…
Taking a ‘trip’ to improve mental health
A clinical trial involving a psychedelic drug and psychotherapy aims to help patients with hard-to-treat…
UK government set for psychedelics investment windfall
The UK government is on track for a seven-figure windfall from an investment in a…